NASDAQ: CLLS
Cellectis Sa Stock Ownership - Who owns Cellectis Sa?

Insider buying vs selling

Have Cellectis Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CLLS insiders and whales buy or sell their stock.

CLLS Shareholders

What type of owners hold Cellectis Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bgroup0.00%3,282$5.02kInstitution
B Group Inc0.00%3,281$5.02kInstitution
Lonfoc0.00%2,742$4.20kInstitution
Long Focus Capital Management LLC0.00%2,741$4.19kInstitution
Umdbuu0.00%2,645$4.05kInstitution
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC0.00%2,644$4.05kInstitution
Nomur10.00%227$347.31Institution
Nomura Asset Management International Inc0.00%226$345.78Institution
Blackrock Inc0.00%225$344.25Institution
Blkrok0.00%225$344.25Institution

1 of 3

CLLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLLS0.01%0.00%
BDTX0.06%35.18%Net Buying
TLSA0.00%81.38%Net BuyingNet Buying
MIST0.04%10.86%Net Selling
GNLX0.02%9.70%Net SellingNet Selling

Cellectis Sa Stock Ownership FAQ

Who owns Cellectis Sa?

Cellectis Sa (NASDAQ: CLLS) is owned by 0.01% institutional shareholders, 0.00% Cellectis Sa insiders, and 99.99% retail investors. Bgroup is the largest individual Cellectis Sa shareholder, owning 3282.00 shares representing 0.00% of the company. Bgroup's Cellectis Sa shares are currently valued at $5.02k.

If you're new to stock investing, here's how to buy Cellectis Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.